Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.
Vrijmoeth HD, Ursinus J, Harms MG, Tulen AD, Baarsma ME, van de Schoor FR, Gauw SA, Zomer TP, Vermeeren YM, Ferreira JA, Sprong H, Kremer K, Knoop H, Joosten LAB, Kullberg BJ, Hovius JW, van den Wijngaard CC. Vrijmoeth HD, et al. Among authors: vermeeren ym. EBioMedicine. 2023 Dec;98:104825. doi: 10.1016/j.ebiom.2023.104825. Epub 2023 Nov 27. EBioMedicine. 2023. PMID: 38016860 Free PMC article.
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
Vrijmoeth HD, Ursinus J, Harms MG, Zomer TP, Gauw SA, Tulen AD, Kremer K, Sprong H, Knoop H, Vermeeren YM, van Kooten B, Joosten LAB, Kullberg BJ, Hovius JWR, van den Wijngaard CC. Vrijmoeth HD, et al. Among authors: vermeeren ym. BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8. BMC Infect Dis. 2019. PMID: 30987580 Free PMC article.
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: vermeeren ym. Lancet Reg Health Eur. 2021 May 27;6:100142. doi: 10.1016/j.lanepe.2021.100142. eCollection 2021 Jul. Lancet Reg Health Eur. 2021. PMID: 34557833 Free PMC article.
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: vermeeren ym. Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr. Lancet Reg Health Eur. 2023. PMID: 36968322 Free PMC article.
Nonspecific Symptoms in Children Referred to a Lyme Borreliosis Center.
Zomer TP, Bruinsma RA, Vermeeren YM, Landman GW, van Hees BC, van Bemmel T, van Kooten B. Zomer TP, et al. Among authors: vermeeren ym. Pediatr Infect Dis J. 2020 Sep;39(9):775-780. doi: 10.1097/INF.0000000000002675. Pediatr Infect Dis J. 2020. PMID: 32379202
Non-specific symptoms in adult patients referred to a Lyme centre.
Zomer TP, Barendregt JNM, van Kooten B, van Bemmel T, Landman GW, van Hees BC, Vermeeren YM. Zomer TP, et al. Among authors: vermeeren ym. Clin Microbiol Infect. 2019 Jan;25(1):67-70. doi: 10.1016/j.cmi.2018.09.016. Epub 2018 Oct 2. Clin Microbiol Infect. 2019. PMID: 30287411 Free article.
27 results